Grotenhermen, Franjo
Center for Cannabis Medicine,
Germany
2025 Rank: 64958
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Substance Abuse
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 129 out of 17312 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64958 | 75338 |
| Total Cites | 239 | 242 |
| H-index | 7 | 7 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 36 | 36 |
| Total Cites to Single Authored Papers | 129 | 129 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 154 | 155 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 228 | 230 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 219 | 220 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.10 |
| Self-Citation Percentage |
1.24%
|
|
Grotenhermen, Franjo
International Association for Cannabinoid Medicines,
Germany
2024 Rank: 41503
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Substance Abuse
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 90 out of 16370 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41503 | 48183 |
| Total Cites | 307 | 308 |
| H-index | 8 | 8 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 36 | 36 |
| Total Cites to Single Authored Papers | 147 | 147 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 194 | 195 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 285 | 286 |
| Composite Score | 3 | 2 |
| Number of Distinct Citing Papers | 277 | 278 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.11 |
| Self-Citation Percentage |
0.32%
|
|
Grotenhermen, Franjo
Nova-Institut GmbH,
Germany
2023 Rank: 58071
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Substance Abuse
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 160 out of 15589 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 58071 | 67946 |
| Total Cites | 280 | 282 |
| H-index | 6 | 6 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 131 | 131 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 174 | 174 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 261 | 262 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 251 | 253 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.11 |
| Self-Citation Percentage |
0.71%
|
|
Grotenhermen, Franjo
International Association for Cannabinoid Medicines (IACM),
Germany
2022 Rank: 57218
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Substance Abuse
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 149 out of 14534 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57218 | 67363 |
| Total Cites | 283 | 285 |
| H-index | 6 | 6 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 32 | 32 |
| Total Cites to Single Authored Papers | 132 | 132 |
| Number of Single+First Authored Papers | 44 | 44 |
| Total Cites to Single+First Authored Papers | 173 | 174 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 274 | 276 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 251 | 253 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.13 |
| Self-Citation Percentage |
0.70%
|
|
Grotenhermen, Franjo
Nova-Institut GmbH,
Germany
2021 Rank: 54566
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Substance Abuse
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 162 out of 13890 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 54566 | 60035 |
| Total Cites | 315 | 319 |
| H-index | 8 | 9 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 210 | 210 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 275 | 278 |
| Number of Single+First+Last Authored Papers | 47 | 47 |
| Total Cites to Single+First+Last Authored Papers | 304 | 308 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 281 | 285 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.12 |
| Self-Citation Percentage |
1.25%
|
|
Grotenhermen, Franjo
None,
Germany
2020 Rank: 51105
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Substance Abuse
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 176 out of 12500 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 51105 | 59848 |
| Total Cites | 259 | 261 |
| H-index | 7 | 7 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 155 | 155 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 216 | 218 |
| Number of Single+First+Last Authored Papers | 47 | 47 |
| Total Cites to Single+First+Last Authored Papers | 248 | 250 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 236 | 238 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.10 |
| Self-Citation Percentage |
0.77%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.